Title : A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

Pub. Date : 2020 Sep

PMID : 32436244






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease? nab erb-b2 receptor tyrosine kinase 2 Homo sapiens